title: Genetics of endometrial cancers.
abstract: Endometrial cancers exhibit a different mechanism of tumorigenesis and progression depending on histopathological and clinical types. The most frequently altered gene in estrogen-dependent endometrioid endometrial carcinoma tumors is PTEN. Microsatellite instability is another important genetic event in this type of tumor. In contrast, p53 mutations or Her2/neu overexpression are more frequent in non-endometrioid tumors. On the other hand, it is possible that the clear cell type may arise from a unique pathway which appears similar to the ovarian clear cell carcinoma. K-ras mutations are detected in approximately 15%-30% of endometrioid carcinomas, are unrelated to the existence of endometrial hyperplasia. A beta-catenin mutation was detected in about 20% of endometrioid carcinomas, but is rare in serous carcinoma. Telomere shortening is another important type of genomic instability observed in endometrial cancer. Only non-endometrioid endometrial carcinoma tumors were significantly associated with critical telomere shortening in the adjacent morphologically normal epithelium. Lynch syndrome, which is an autosomal dominantly inherited disorder of cancer susceptibility and is characterized by a MSH2/MSH6 protein complex deficiency, is associated with the development of non-endometrioid carcinomas.
authors.affiliation: Department of Obstetrics and Gynecology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8666, Japan.
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Okuda
authors.forename: Akihiko
authors.initials: A
authors.lastname: Sekizawa
authors.forename: Yuditiya
authors.initials: Y
authors.lastname: Purwosunu
authors.forename: Masaaki
authors.initials: M
authors.lastname: Nagatsuka
authors.forename: Miki
authors.initials: M
authors.lastname: Morioka
authors.forename: Masaki
authors.initials: M
authors.lastname: Hayashi
authors.forename: Takashi
authors.initials: T
authors.lastname: Okai
references.citation: Pathology. 2007 Feb;39(1):46-54
references.pmid: 17365822
references.citation: Am J Pathol. 2001 Jun;158(6):2097-106
references.pmid: 11395387
references.citation: Cancer Lett. 2008 Feb 8;259(2):146-55
references.pmid: 18006148
references.citation: Int J Cancer. 2000 Apr 1;86(1):60-6
references.pmid: 10728595
references.citation: Gynecol Oncol. 1989 Oct;35(1):50-4
references.pmid: 2792902
references.citation: Mol Carcinog. 1999 Jul;25(3):207-18
references.pmid: 10411147
references.citation: J Mol Diagn. 2005 Feb;7(1):8-16
references.pmid: 15681469
references.citation: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):477-86
references.pmid: 14623547
references.citation: J Obstet Gynaecol Res. 2008 Oct;34(5):776-83
references.pmid: 18958927
references.citation: Cancer Sci. 2007 May;98(5):652-8
references.pmid: 17388789
references.citation: Gynecol Oncol. 1983 Feb;15(1):10-7
references.pmid: 6822361
references.citation: Virchows Arch. 2004 Aug;445(2):129-34
references.pmid: 15221375
references.citation: Int J Cancer. 2001 Jan 1;91(1):22-6
references.pmid: 11149415
references.citation: J Cancer Res Clin Oncol. 1998;124(12):695-700
references.pmid: 9879831
references.citation: Cancer. 2002 May 1;94(9):2369-79
references.pmid: 12015762
references.citation: Hum Pathol. 1995 Nov;26(11):1268-74
references.pmid: 7590703
references.citation: Gynecol Oncol. 2006 Nov;103(2):684-7
references.pmid: 16797683
references.citation: Oncogene. 2002 Nov 14;21(52):7981-90
references.pmid: 12439748
references.citation: Mod Pathol. 2004 May;17(5):530-7
references.pmid: 14976538
references.citation: Hum Pathol. 1998 Oct;29(10):1150-9
references.pmid: 9781657
references.citation: BJOG. 2009 Jul;116(8):1053-61
references.pmid: 19438492
references.citation: Br J Cancer. 2009 Jul 7;101(1):145-8
references.pmid: 19491896
references.citation: J Natl Cancer Inst. 1995 Aug 2;87(15):1114-25
references.pmid: 7674315
references.citation: Eur J Cancer Prev. 2008 Apr;17(2):133-8
references.pmid: 18287870
references.citation: Chem Res Toxicol. 1991 Jul-Aug;4(4):391-407
references.pmid: 1912325
references.citation: Clin Cancer Res. 2009 Sep 15;15(18):5784-93
references.pmid: 19737954
references.citation: Mod Pathol. 2005 Mar;18(3):340-8
references.pmid: 15257317
references.citation: Int J Oncol. 2009 Jun;34(6):1541-7
references.pmid: 19424571
references.citation: Cancer. 2000 Feb 15;88(4):814-24
references.pmid: 10679651
references.citation: Cancer. 1995 Nov 15;76(10 Suppl):2034-40
references.pmid: 8634996
references.citation: J Natl Cancer Inst. 2000 Jun 7;92(11):924-30
references.pmid: 10841828
references.citation: Ann N Y Acad Sci. 2003 Mar;983:208-12
references.pmid: 12724225
references.citation: Am J Pathol. 2009 Jun;174(6):2107-15
references.pmid: 19389926
references.citation: Cancer Res. 1994 Mar 15;54(6):1604-7
references.pmid: 8137266
references.citation: Hum Pathol. 1998 Jun;29(6):551-8
references.pmid: 9635673
references.citation: Gynecol Oncol. 2003 Mar;88(3):318-25
references.pmid: 12648581
references.citation: Histopathology. 2009 Sep;55(3):243-9
references.pmid: 19469886
references.citation: Cancer Res. 2009 Sep 1;69(17):7038-45
references.pmid: 19690133
references.citation: Gynecol Oncol. 2007 Oct;107(1):143-53
references.pmid: 17692907
references.citation: Gynecol Oncol. 2010 Mar;116(3):533-8
references.pmid: 20006376
references.citation: Cancer Control. 2009 Jan;16(1):8-13
references.pmid: 19078924
references.citation: Int J Cancer. 2005 Jul 20;115(6):930-4
references.pmid: 15723290
references.citation: Cancer Sci. 2008 Sep;99(9):1715-9
references.pmid: 18624996
references.citation: Oncogene. 2008 Sep 18;27(41):5497-510
references.pmid: 18794884
references.citation: J Clin Oncol. 2004 Aug 1;22(15):3126-32
references.pmid: 15284264
references.citation: J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):221-9
references.pmid: 18061438
references.citation: Am J Pathol. 1997 Jan;150(1):177-85
references.pmid: 9006334
references.citation: APMIS. 2009 Oct;117(10):693-707
references.pmid: 19775337
references.citation: Drug Metab Rev. 1994;26(1-2):165-83
references.pmid: 8082563
references.citation: Exp Mol Pathol. 1999 Dec;67(3):135-43
references.pmid: 10600396
references.citation: Gynecol Oncol. 1990 Jul;38(1):22-7
references.pmid: 2354822
references.citation: Cancer Res. 1998 Jun 15;58(12):2500-3
references.pmid: 9635567
references.citation: Cancer Res. 2008 Sep 1;68(17):6902-7
references.pmid: 18757403
references.citation: Gastroenterology. 1997 Oct;113(4):1146-58
references.pmid: 9322509
references.citation: Cancer Res. 2001 Apr 1;61(7):2813-5
references.pmid: 11306449
references.citation: Cancer Res. 1993 Apr 15;53(8):1906-10
references.pmid: 8467512
references.citation: Gynecol Oncol. 1999 Jan;72(1):51-5
references.pmid: 9889029
references.citation: Am J Pathol. 2001 Jun;158(6):1895-8
references.pmid: 11395362
references.citation: Lancet Oncol. 2009 Apr;10(4):400-8
references.pmid: 19341971
references.citation: Clin Cancer Res. 2003 Jun;9(6):2277-87
references.pmid: 12796396
references.citation: Eur J Cancer. 1997 Sep;33(10):1572-7
references.pmid: 9389917
references.citation: Cancer. 1999 Jan 1;85(1):119-26
references.pmid: 9921983
references.citation: Future Oncol. 2009 Feb;5(1):27-32
references.pmid: 19243295
references.citation: Am J Pathol. 2008 Aug;173(2):536-44
references.pmid: 18599611
references.citation: N Engl J Med. 2006 Jan 19;354(3):270-82
references.pmid: 16421368
references.citation: Cancer J. 2003 Sep-Oct;9(5):335-47
references.pmid: 14690308
references.citation: Br J Cancer. 2009 Oct 6;101(7):1218-9; author reply 1220-1
references.pmid: 19738612
references.citation: Gynecol Oncol. 2010 Jan;116(1):131-9
references.pmid: 19853898
references.citation: J Oncol. 2010;2010:139087
references.pmid: 19884980
references.citation: Clin Cancer Res. 2005 Sep 15;11(18):6422-30
references.pmid: 16166416
references.citation: Clin Cancer Res. 2005 Sep 1;11(17):6133-8
references.pmid: 16144912
references.citation: Oncol Rep. 2006 Dec;16(6):1189-96
references.pmid: 17089036
references.citation: J Clin Oncol. 2005 Jul 20;23(21):4609-16
references.pmid: 15837969
references.citation: J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35
references.pmid: 8757192
references.citation: Gynecol Oncol. 2005 Oct;99(1):126-34
references.pmid: 16023706